ripekg:evaluation/RIPEA02C7C24523188961 |
rdf:type |
rdfs:Resource |
ripekg:evaluation/RIPEA02C7C24523188961 |
rdf:type |
owl:Thing |
ripekg:evaluation/RIPEA02C7C24523188961 |
rdf:type |
tido:Evaluation |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:endedAtTime |
2025-11-13T15:46:24.993133Z |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:startedAtTime |
2025-11-13T15:37:27.850726Z |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:publication-details/RIPEA02C7C24523188961Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:registry-evidence/RIPEA02C7C24523188961 |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/10303Risedronate Therapy for Prevention of Hip Fracture After Stroke in Elderly Women. Reply to Authors |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/10309Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/11839Beneficial Effect of Etidronate Therapy in Immobilized Hip Fracture Patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/12296Low-Dose Vitamin D Prevents Muscular Atrophy and Reduces Falls and Hip Fractures in Women after Stroke: A Randomized Controlled Trial |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/16226Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer’s disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/16920Beneficial Effect of Etidronate Therapy in Immobilized Hip Fracture Patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/16986Cardiac Involvement in Malignant Syndrome in Parkinson’s Disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/17011Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson’s disease -Authors' Reply |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/17309Development of Osteopenia in the Hemiplegic Finger in Patients with Stroke |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/17474Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/17807Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/17809Does compensatory hyperparathyroidism predispose to ischemic stroke? |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/19125Negative myoglobin staining in hemiplegic muscle of acute stroke patients predicts functional recovery |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/19309Abnormal calcium homeostasis in disabled stroke patients with low 25-hydroxyvitamin D |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/19310Homocysteine as a predictive factor for hip fracture in stroke patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/19830Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/19837Morphological and histochemical study of nonhemiplegic muscle in acute stroke patients manifesting respiratory failure |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/19838Morphologic and Histochemical Evaluation of Muscle in Patients with Chronic Pulmonary Emphysema Manifesting Generalized Emaciation |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/19932Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/20166Vitamin K Deficiency and Osteopenia in Vitamin D-Deficient Elderly Women With Parkinson's Disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/20167Vitamin K Deficiency and Osteopenia in Elderly Women With Alzheimer's Disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/20853Diagnostic value of atypical lymphocytes in cerebrospinal fluid from adults with enteroviral meningitis |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/20917Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/20918Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/20921Vitamin D deficiency and risk of hip fractures among disabled elderly stroke patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/20960Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/20971Beneficial Effect of Etidronate Therapy in Chronically Hospitalized, Disabled Patients with Stroke |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/20973Accelerated bone remodeling in patients with poststroke hemiplegia |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/21140Long-Term Oral Anticoagulation Therapy and the Risk of Hip Fracture in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/21506An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/21659Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/22992Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/22993Does compensatory hyperparathyroidism predispose to ischemic stroke? |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/23125Subdural hematoma following disappearance of orthostatic headache and pressure normalization in two patients with spontaneous intracranial hypotension |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/23126Recurrence of spontaneous intracranial hypotension with subdural hematomas |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/24392Beneficial Effect of Etidronate on Bone Loss After Cessation of Exercise in Postmenopausal Osteoporotic Women |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/24584Influence of gastrectomy on cortical and cancellous bones in rats |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/24589Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/25496Effect of alendronate on bone mineral density and bone turnovermarkers in post-gastrectomy osteoporotic patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/26182Effect of intermittent administration of hPTH(1-34) on cortical bone geometry in rats treated with high-dose glucocorticoids |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/29812Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/29909Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/29915Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/30868Effects of Vitamin K2 on Osteoporosis |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/36164Vitamin D Reduces Falls and Hip Fractures in Vascular Parkinsonism but Not in Parkinson’s Disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/38228Differential effect of treadmill exercise on three cancellous bone sites in the young growing rat |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/38511Effect of Treadmill Exercise on Bone Mass in Female Rats |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/38532Vitamin D Reduces Falls and Hip Fractures in Vascular Parkinsonism but Not in Parkinson’s Disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/39373Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/42815A Radiographic Study on the Associations of Age and Prevalence of Vertebral Fractures with Abdominal Aortic Calcification in Japanese Postmenopausal Women and Men |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/42875Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/43037Comparative effects of vitamin K and vitamin D supplementation on prevention of osteopenia in calcium-deficient young rats |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/44213Efficacy of Oral Etidronate for Skeletal Diseases in Japan |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/4480Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/49930Risk factors for hip fracture among elderly patients with Alzheimer's disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/50206Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/50210Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: Effect of combined therapy with folic acid and mecobalamine |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/50211Risk factors for hip fracture among elderly patients with Parkinson's disease |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/50212Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/50213Amelioration by mecobalamin of subclinical carpal tunnel syndrome involving unaffected limbs in stroke patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/52406Histiocytic necrotizing lymphadenitis (Kikuchi's disease) with aseptic meningitis |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/52407Rapid diagnosis of cryptococcal meningitis by microscopic examination of centrifuged cerebrospinal fluid sediment |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/52486Cerebrospinal fluid atypical lymphocytes in Japanese encephalitis |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/5362Beneficial Effect of Intermittent Cyclical Etidronate Therapy in Hemiplegic Patients Following an Acute Stroke |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/56206Reply to Davie and Sharp: Different mechanisms of bone metabolism between patients with stroke and with spinal cord injury |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/5729The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: A randomized controlled trial |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/57573Role of Vitamin K2 in the Treatment of Postmenopausal Osteoporosis |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/6555Risedronate Therapy for Prevention of Hip Fracture After Stroke in Elderly Women |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/9558Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/9569Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:study-design-evidence/RIPEA02C7C24523188961 |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:wasAssociatedWith |
ripekg:human-reviewer/RV013 |
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEA02C7C24523188961 |
ripekg:evaluation/RIPEA02C7C24523188961 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA02C7C24523188961 |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-human-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA02C7C24523188961 |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-human-1-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA02C7C24523188961 |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-human-1-3 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA02C7C24523188961 |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-human-2-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA02C7C24523188961 |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-human-overall |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA02C7C24523188961 |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-inspectai-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA02C7C24523188961 |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-inspectai-1-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA02C7C24523188961 |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-inspectai-1-3 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA02C7C24523188961 |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-inspectai-2-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA02C7C24523188961 |